Evolent Health (EVH) Leases (2019 - 2026)

Evolent Health has reported Leases for 8 years, with the latest figure at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 32.48% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (down 32.48% YoY), and the FY2025 full-year result was $4.4 million, down 28.71% from the prior year.
• Leases for Q1 2026 stood at $3.9 million, down from $4.4 million in the prior quarter.
• The five-year high for Leases was $50.9 million in Q2 2022, with the low at $3.9 million in Q1 2026.
• Average Leases over 5 years is $21.2 million, with a median of $10.8 million recorded in 2024.
• Year-over-year, Leases climbed 1.15% in 2022 and slumped 75.7% in 2024.
• Tracing EVH's Leases over 5 years: stood at $49.0 million in 2022, then slumped by 75.56% to $12.0 million in 2023, then tumbled by 48.81% to $6.1 million in 2024, then declined by 28.71% to $4.4 million in 2025, then declined by 11.59% to $3.9 million in 2026.
• The last three Leases figures came in at $3.9 million (Q1 2026), $4.4 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.

Peer Comparison